Kodiak Sciences Inc Share Price

Kodiak Sciences Inc Share Price

NASDAQ: KOD | Mid Cap
$100.26
+$3.43 (3.54%) Last updated on 30 Oct, 2026 | 02:14 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Kodiak Sciences Inc Stock Performance

Open
$97.10
Prev. Close
$96.83
Circuit Range
N/A
Day Range
$97.10 - $103.37
Year Range
$15.93 - $103.99
Volume
56,227
Average Traded
$100.65

Kodiak Sciences Inc Share Price Today

As of 30 October 2026, Kodiak Sciences Inc's share price is $100.26. The stock opened at $97.10, compared to its previous close of $96.83. During today's trading session, Kodiak Sciences Inc's share price traded between $97.10 and $103.37, with an average price of $100.23. Over the past 52 weeks, the stock has recorded a high of $103.99 and a low of $15.93. In terms of performance, Kodiak Sciences Inc's share price has risen by 130.14% over the last six months and is up 453.16% on a year-on-year basis.

Kodiak Sciences Inc Share Price Chart

Line chart of the Kodiak Sciences Inc price trend over the selected period. The price rose overall, ranging from 97.10 to 103.58, ending at 100.43.
$97.10$103.37
L
Show Current Price
H

Kodiak Sciences Inc Stock Fundamentals & Key Indicators

Market Cap
$5.33B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-3.85
Revenue (TTM)
$0.00
Return On Equity (TTM)
-396.09%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-6.80%

Kodiak Sciences Inc Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$61.46-$56.74-$58.16-$65.64
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A7.68%-2.50%-12.86%

Kodiak Sciences Inc Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$333.82-$260.49-$176.21-$229.97
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A21.97%32.35%-30.51%

About Kodiak Sciences Inc

Kodiak Sciences Inc has developed a new technology platform, the Antibody Biopolymer Conjugate (ABC) platform, for retinal medicines. Its investigational medicine, tarcocimab tedromer (Zenkuda or tarcocimab), is an anti-VEGF therapy built on Kodiak's proprietary ABC platform. Another investigational medicine, KSI-501, is an anti-interleukin 6, or IL-6, VEGF-trap bispecific therapy built on the ABC platform and is being developed for high-prevalence retinal vascular diseases and intended to address the unmet needs of extended durability and targeting disease biology beyond VEGF for differentiated efficacy. Its third investigational medicine, KSI-101, is a high-strength (100 mg/mL) bispecific protein targeting IL-6 and VEGF.

Kodiak Sciences Inc Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$98.61
$100.75
+6.14%
Sep 2026
$37.01
$94.93
+142.79%
Aug 2026
$40.77
$39.10
-5.89%
Jul 2026
$38.22
$41.55
+6.64%
Jun 2026
$35.19
$38.96
+6.29%
May 2026
$43.91
$36.66
-15.86%
Apr 2026
$40.27
$43.56
+13.98%
Mar 2026
$27.14
$38.22
+42.83%
Feb 2026
$23.04
$26.76
+17.50%
Jan 2026
$28.23
$22.77
-18.50%
Dec 2025
$22.48
$27.95
+21.45%
Nov 2025
$18.13
$23.01
+26.95%

KOD Share Price FAQs